Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbe Robotics (ARBE) Gains from Investment Securities (2020 - 2025)

Historic Gains from Investment Securities for Arbe Robotics (ARBE) over the last 6 years, with Q3 2025 value amounting to -$85000.0.

  • Arbe Robotics' Gains from Investment Securities fell 2686.57% to -$85000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$204000.0, marking a year-over-year increase of 6611.3%. This contributed to the annual value of $660000.0 for FY2024, which is 8694.94% down from last year.
  • Arbe Robotics' Gains from Investment Securities amounted to -$85000.0 in Q3 2025, which was down 2686.57% from $273000.0 recorded in Q2 2025.
  • Over the past 5 years, Arbe Robotics' Gains from Investment Securities peaked at $3.3 million during Q1 2021, and registered a low of -$3.4 million during Q4 2022.
  • Its 5-year average for Gains from Investment Securities is -$148421.1, with a median of -$112000.0 in 2024.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first crashed by 33666.27% in 2022, then surged by 27388.54% in 2025.
  • Over the past 5 years, Arbe Robotics' Gains from Investment Securities (Quarter) stood at $1.9 million in 2021, then crashed by 280.6% to -$3.4 million in 2022, then soared by 92.09% to -$266000.0 in 2023, then skyrocketed by 57.89% to -$112000.0 in 2024, then grew by 24.11% to -$85000.0 in 2025.
  • Its last three reported values are -$85000.0 in Q3 2025, $273000.0 for Q2 2025, and -$280000.0 during Q1 2025.